CLS.TO vs. IDXX
CLS.TO (Celestica Inc.) and IDXX (IDEXX Laboratories, Inc.) are both stocks. CLS.TO operates in Electronic Components (Technology), while IDXX operates in Diagnostics & Research (Healthcare). Over the past 10 years, CLS.TO returned 40.06%/yr vs 20.00%/yr for IDXX. At a 0.23 correlation, their price movements are largely independent.
Performance
CLS.TO vs. IDXX - Performance Comparison
Loading charts...
Different Trading Currencies
CLS.TO is traded in CAD, while IDXX is traded in USD. To make them comparable, the IDXX values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, CLS.TO achieves a 5.93% return, which is significantly higher than IDXX's -17.21% return. Over the past 10 years, CLS.TO has outperformed IDXX with an annualized return of 40.06%, while IDXX has yielded a comparatively lower 20.00% annualized return.
CLS.TO
- 1D
- -8.67%
- 1M
- -16.62%
- 6M
- 3.50%
- YTD
- 5.93%
- 1Y
- 92.16%
- 3Y*
- 170.29%
- 5Y*
- 115.61%
- 10Y*
- 40.06%
- ALL TIME*
- 20.52%
IDXX
- 1D
- 0.97%
- 1M
- -1.70%
- 6M
- -19.80%
- YTD
- -17.21%
- 1Y
- 2.54%
- 3Y*
- 1.51%
- 5Y*
- -2.52%
- 10Y*
- 20.00%
- ALL TIME*
- 18.69%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
CLS.TO Celestica Inc. | CA$159.61M | CA$161.91M | CA$209.67M |
| CA$439.37M | CA$523.03M | CA$506.61M |
CLS.TO vs. IDXX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CLS.TO Celestica Inc. | 5.93% | 206.05% | 241.82% | 154.33% | 8.23% | 37.29% | -4.64% | -9.95% | -9.26% | -17.16% |
IDXX IDEXX Laboratories, Inc. | -17.21% | 56.16% | -19.21% | 32.82% | -34.12% | 31.66% | 86.88% | 34.59% | 28.96% | 24.32% |
Correlation
The correlation between CLS.TO and IDXX is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Aug 23, 2006 | 0.23 |
The correlation between CLS.TO and IDXX shifts across timeframes, from 0.12 (1 year) to 0.25 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
CLS.TO:
CA$49.45B
IDXX:
$42.94B
CLS.TO:
$8.29
IDXX:
$20.36
CLS.TO:
36.89
IDXX:
26.73
CLS.TO:
0.50
IDXX:
2.31
CLS.TO:
2.56
IDXX:
6.58
CLS.TO:
$13.81B
IDXX:
$4.45B
CLS.TO:
$1.60B
IDXX:
$2.76B
CLS.TO:
$1.36B
IDXX:
$1.52B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CLS.TO vs. IDXX — Risk / Return Rank
CLS.TO
IDXX
CLS.TO vs. IDXX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Celestica Inc. (CLS.TO) and IDEXX Laboratories, Inc. (IDXX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CLS.TO | IDXX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.19 | ||
| Sortino ratioReturn per unit of downside risk | +1.33 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.06 | +0.18 |
| Calmar ratioReturn relative to maximum drawdown | 2.62 | 0.08 | +2.54 |
| Martin ratioReturn relative to average drawdown | 5.99 | 0.13 | +5.86 |
Loading charts...
Drawdowns
CLS.TO vs. IDXX - Drawdown Comparison
The maximum CLS.TO drawdown since its inception was -79.32%, which is greater than IDXX's maximum drawdown of -52.40%. Use the drawdown chart below to compare losses from any high point for CLS.TO and IDXX.
Loading charts...
Drawdown Indicators
| CLS.TO | IDXX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.32% | -52.40% | -26.92% |
Max Drawdown (1Y)Largest decline over 1 year | -35.38% | -33.06% | -2.32% |
Max Drawdown (3Y)Largest decline over 3 years | -54.25% | -34.35% | -19.90% |
Max Drawdown (5Y)Largest decline over 5 years | -54.25% | -52.40% | -1.85% |
Max Drawdown (10Y)Largest decline over 10 years | -79.32% | -52.40% | -26.92% |
Current DrawdownCurrent decline from peak | -34.12% | -29.09% | -5.03% |
Average DrawdownAverage peak-to-trough decline | -28.95% | -12.44% | -16.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.44% | 19.03% | -3.59% |
Volatility
CLS.TO vs. IDXX - Volatility Comparison
Celestica Inc. (CLS.TO) has a higher volatility of 22.74% compared to IDEXX Laboratories, Inc. (IDXX) at 9.51%. This indicates that CLS.TO's price experiences larger fluctuations and is considered to be riskier than IDXX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CLS.TO | IDXX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.74% | 9.51% | +13.23% |
Volatility (6M)Calculated over the trailing 6-month period | 55.70% | 22.31% | +33.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 74.44% | 42.70% | +31.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 57.51% | 35.88% | +21.63% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.30% | 33.68% | +15.62% |
Dividends
CLS.TO vs. IDXX - Dividend Comparison
Neither CLS.TO nor IDXX has paid dividends to shareholders.
Financials
CLS.TO vs. IDXX - Financials Comparison
This section allows you to compare key financial metrics between Celestica Inc. and IDEXX Laboratories, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CLS.TO vs. IDXX - Profitability Comparison
CLS.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Celestica Inc. reported a gross profit of 437.20M and revenue of 4.05B. Therefore, the gross margin over that period was 10.8%.
IDXX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, IDEXX Laboratories, Inc. reported a gross profit of 722.74M and revenue of 1.14B. Therefore, the gross margin over that period was 63.4%.
CLS.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Celestica Inc. reported an operating income of 267.70M and revenue of 4.05B, resulting in an operating margin of 6.6%.
IDXX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, IDEXX Laboratories, Inc. reported an operating income of 362.59M and revenue of 1.14B, resulting in an operating margin of 31.8%.
CLS.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Celestica Inc. reported a net income of 212.30M and revenue of 4.05B, resulting in a net margin of 5.3%.
IDXX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, IDEXX Laboratories, Inc. reported a net income of 278.45M and revenue of 1.14B, resulting in a net margin of 24.4%.
Frequently Asked Questions
CLS.TO and IDXX have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CLS.TO and IDXX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer